Literature DB >> 26714712

Methods to Study Determinants for Membrane Targeting of HIV-1 Gag In Vitro.

Gabrielle C Todd1, Akira Ono2.   

Abstract

Assembly of HIV-1 viral particles is a critical step of the HIV-1 life cycle; yet many details of this complex process are unknown. The Gag polyprotein drives viral particle assembly at the plasma membrane via three different types of interactions: protein-protein, protein-RNA, and protein-membrane interactions. As an approach to tease apart the importance of these interactions during viral particle assembly, in particular at the step of Gag membrane binding, we have developed an in vitro liposome-binding assay. Below we describe how to prepare liposomes, which serve as model membranes, and how to assess their interaction with Gag by liposome flotation centrifugation. Additionally, we outline extensions of this basic assay that can be used to address the role of RNA in regulating Gag-membrane interactions.

Entities:  

Keywords:  Gag; HIV-1 assembly; Liposome flotation centrifugation; Membrane binding; RNA

Mesh:

Substances:

Year:  2016        PMID: 26714712      PMCID: PMC5030775          DOI: 10.1007/978-1-4939-3046-3_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  21 in total

1.  Entropic switch regulates myristate exposure in the HIV-1 matrix protein.

Authors:  Chun Tang; Erin Loeliger; Paz Luncsford; Isaac Kinde; Dorothy Beckett; Michael F Summers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

2.  Synthesis of RNA by in vitro transcription.

Authors:  Bertrand Beckert; Benoît Masquida
Journal:  Methods Mol Biol       Date:  2011

3.  Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag.

Authors:  Jingga Inlora; Vineela Chukkapalli; David Derse; Akira Ono
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

4.  In vitro reconstitution of the ordered assembly of the endosomal sorting complex required for transport at membrane-bound HIV-1 Gag clusters.

Authors:  Lars-Anders Carlson; James H Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

5.  Evidence in support of RNA-mediated inhibition of phosphatidylserine-dependent HIV-1 Gag membrane binding in cells.

Authors:  Vineela Chukkapalli; Jingga Inlora; Gabrielle C Todd; Akira Ono
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

6.  Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection.

Authors:  P Purohit; S Dupont; M Stevenson; M R Green
Journal:  RNA       Date:  2001-04       Impact factor: 4.942

7.  Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids.

Authors:  Ayna Alfadhli; Amelia Still; Eric Barklis
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

8.  Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.

Authors:  Vineela Chukkapalli; Seung J Oh; Akira Ono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

9.  Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding.

Authors:  Vineela Chukkapalli; Ian B Hogue; Vitaly Boyko; Wei-Shau Hu; Akira Ono
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

Review 10.  The molecular basis of HIV capsid assembly--five years of progress.

Authors:  Catherine S Adamson; Ian M Jones
Journal:  Rev Med Virol       Date:  2004 Mar-Apr       Impact factor: 6.989

View more
  1 in total

1.  Inhibition of HIV-1 Gag-membrane interactions by specific RNAs.

Authors:  Gabrielle C Todd; Alice Duchon; Jingga Inlora; Erik D Olson; Karin Musier-Forsyth; Akira Ono
Journal:  RNA       Date:  2016-12-08       Impact factor: 4.942

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.